Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.457-459
Main Authors: Pipe, Steven W., Collins, Peter, Dhalluin, Christophe, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Peyvandi, Flora, Young, Guy, Oldenburg, Johannes, Mancuso, Maria Elisa, Kiialainen, Anna, Chang, Tiffany, Lehle, Michaela, Fijnvandraat, Karin
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1854-323076e2a8d174422d4d03b005531e9ec055481e5ee94e8770a29f680f7239fc3
cites
container_end_page 459
container_issue Supplement 1
container_start_page 457
container_title Blood
container_volume 140
creator Pipe, Steven W.
Collins, Peter
Dhalluin, Christophe
Kenet, Gili
Schmitt, Christophe
Buri, Muriel
Jiménez-Yuste, Víctor
Peyvandi, Flora
Young, Guy
Oldenburg, Johannes
Mancuso, Maria Elisa
Kiialainen, Anna
Chang, Tiffany
Lehle, Michaela
Fijnvandraat, Karin
description
doi_str_mv 10.1182/blood-2022-157264
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_157264</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000649712201730X</els_id><sourcerecordid>S000649712201730X</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1854-323076e2a8d174422d4d03b005531e9ec055481e5ee94e8770a29f680f7239fc3</originalsourceid><addsrcrecordid>eNp9kE1OwzAQhS0EEqVwAHa-QGDsOE0Cqwq1NFIFiALbyHXGqlESI9stlOtwUdyWNav50_fe6BFyyeCKsYJfL1trm4QD5wnLcj4SR2TAMl4kAByOyQAARokoc3ZKzrx_B2Ai5dmA_Ew6o8z3upNL-uTsx2rbyi_jqbaOhhXSF4cydNgHajWtei374OmnCSu6wA06pDPsImVaI-l4f7DrQKdShSjwVlVVhFZmaeLob-gz-nUbBbSz3V6-6gM609FxL9utj77RZbefjd8mDzSni7ButufkRMvW48VfHZLX6eTlbpbMH--ru_E8UazIRJLyFPIRclk0LBeC80Y0kC4BsixlWKKKjSgYZoilwCLPQfJSjwrQOU9LrdIhYQdd5az3DnX9EX-TblszqHcp1_uU613K9SHlyNweGIyPbQy62iuDvcLGOFShbqz5h_4Fr4uF8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study</title><source>ScienceDirect®</source><creator>Pipe, Steven W. ; Collins, Peter ; Dhalluin, Christophe ; Kenet, Gili ; Schmitt, Christophe ; Buri, Muriel ; Jiménez-Yuste, Víctor ; Peyvandi, Flora ; Young, Guy ; Oldenburg, Johannes ; Mancuso, Maria Elisa ; Kiialainen, Anna ; Chang, Tiffany ; Lehle, Michaela ; Fijnvandraat, Karin</creator><creatorcontrib>Pipe, Steven W. ; Collins, Peter ; Dhalluin, Christophe ; Kenet, Gili ; Schmitt, Christophe ; Buri, Muriel ; Jiménez-Yuste, Víctor ; Peyvandi, Flora ; Young, Guy ; Oldenburg, Johannes ; Mancuso, Maria Elisa ; Kiialainen, Anna ; Chang, Tiffany ; Lehle, Michaela ; Fijnvandraat, Karin</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-157264</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.457-459</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1854-323076e2a8d174422d4d03b005531e9ec055481e5ee94e8770a29f680f7239fc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S000649712201730X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids></links><search><creatorcontrib>Pipe, Steven W.</creatorcontrib><creatorcontrib>Collins, Peter</creatorcontrib><creatorcontrib>Dhalluin, Christophe</creatorcontrib><creatorcontrib>Kenet, Gili</creatorcontrib><creatorcontrib>Schmitt, Christophe</creatorcontrib><creatorcontrib>Buri, Muriel</creatorcontrib><creatorcontrib>Jiménez-Yuste, Víctor</creatorcontrib><creatorcontrib>Peyvandi, Flora</creatorcontrib><creatorcontrib>Young, Guy</creatorcontrib><creatorcontrib>Oldenburg, Johannes</creatorcontrib><creatorcontrib>Mancuso, Maria Elisa</creatorcontrib><creatorcontrib>Kiialainen, Anna</creatorcontrib><creatorcontrib>Chang, Tiffany</creatorcontrib><creatorcontrib>Lehle, Michaela</creatorcontrib><creatorcontrib>Fijnvandraat, Karin</creatorcontrib><title>Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1OwzAQhS0EEqVwAHa-QGDsOE0Cqwq1NFIFiALbyHXGqlESI9stlOtwUdyWNav50_fe6BFyyeCKsYJfL1trm4QD5wnLcj4SR2TAMl4kAByOyQAARokoc3ZKzrx_B2Ai5dmA_Ew6o8z3upNL-uTsx2rbyi_jqbaOhhXSF4cydNgHajWtei374OmnCSu6wA06pDPsImVaI-l4f7DrQKdShSjwVlVVhFZmaeLob-gz-nUbBbSz3V6-6gM609FxL9utj77RZbefjd8mDzSni7ButufkRMvW48VfHZLX6eTlbpbMH--ru_E8UazIRJLyFPIRclk0LBeC80Y0kC4BsixlWKKKjSgYZoilwCLPQfJSjwrQOU9LrdIhYQdd5az3DnX9EX-TblszqHcp1_uU613K9SHlyNweGIyPbQy62iuDvcLGOFShbqz5h_4Fr4uF8w</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Pipe, Steven W.</creator><creator>Collins, Peter</creator><creator>Dhalluin, Christophe</creator><creator>Kenet, Gili</creator><creator>Schmitt, Christophe</creator><creator>Buri, Muriel</creator><creator>Jiménez-Yuste, Víctor</creator><creator>Peyvandi, Flora</creator><creator>Young, Guy</creator><creator>Oldenburg, Johannes</creator><creator>Mancuso, Maria Elisa</creator><creator>Kiialainen, Anna</creator><creator>Chang, Tiffany</creator><creator>Lehle, Michaela</creator><creator>Fijnvandraat, Karin</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study</title><author>Pipe, Steven W. ; Collins, Peter ; Dhalluin, Christophe ; Kenet, Gili ; Schmitt, Christophe ; Buri, Muriel ; Jiménez-Yuste, Víctor ; Peyvandi, Flora ; Young, Guy ; Oldenburg, Johannes ; Mancuso, Maria Elisa ; Kiialainen, Anna ; Chang, Tiffany ; Lehle, Michaela ; Fijnvandraat, Karin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1854-323076e2a8d174422d4d03b005531e9ec055481e5ee94e8770a29f680f7239fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pipe, Steven W.</creatorcontrib><creatorcontrib>Collins, Peter</creatorcontrib><creatorcontrib>Dhalluin, Christophe</creatorcontrib><creatorcontrib>Kenet, Gili</creatorcontrib><creatorcontrib>Schmitt, Christophe</creatorcontrib><creatorcontrib>Buri, Muriel</creatorcontrib><creatorcontrib>Jiménez-Yuste, Víctor</creatorcontrib><creatorcontrib>Peyvandi, Flora</creatorcontrib><creatorcontrib>Young, Guy</creatorcontrib><creatorcontrib>Oldenburg, Johannes</creatorcontrib><creatorcontrib>Mancuso, Maria Elisa</creatorcontrib><creatorcontrib>Kiialainen, Anna</creatorcontrib><creatorcontrib>Chang, Tiffany</creatorcontrib><creatorcontrib>Lehle, Michaela</creatorcontrib><creatorcontrib>Fijnvandraat, Karin</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pipe, Steven W.</au><au>Collins, Peter</au><au>Dhalluin, Christophe</au><au>Kenet, Gili</au><au>Schmitt, Christophe</au><au>Buri, Muriel</au><au>Jiménez-Yuste, Víctor</au><au>Peyvandi, Flora</au><au>Young, Guy</au><au>Oldenburg, Johannes</au><au>Mancuso, Maria Elisa</au><au>Kiialainen, Anna</au><au>Chang, Tiffany</au><au>Lehle, Michaela</au><au>Fijnvandraat, Karin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>457</spage><epage>459</epage><pages>457-459</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-157264</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.457-459
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_157264
source ScienceDirect®
title Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A00%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emicizumab%20Prophylaxis%20for%20the%20Treatment%20of%20Infants%20with%20Severe%20Hemophilia%20A%20without%20Factor%20VIII%20Inhibitors:%20Results%20from%20the%20Interim%20Analysis%20of%20the%20HAVEN%207%20Study&rft.jtitle=Blood&rft.au=Pipe,%20Steven%20W.&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=457&rft.epage=459&rft.pages=457-459&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-157264&rft_dat=%3Celsevier_cross%3ES000649712201730X%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1854-323076e2a8d174422d4d03b005531e9ec055481e5ee94e8770a29f680f7239fc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true